Adrian Hargrave, CEO of SEEEN, explains how the new funds will accelerate customer growth Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTate & Lyle Regulatory News (TATE)

Share Price Information for Tate & Lyle (TATE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 682.00
Bid: 681.50
Ask: 683.00
Change: -1.50 (-0.22%)
Spread: 1.50 (0.22%)
Open: 679.00
High: 684.00
Low: 675.00
Prev. Close: 683.50
TATE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Board changes

29 Oct 2014 10:00

29 October 2014

Tate & Lyle PLC

Board changes

Tate & Lyle PLC (the “Company”) announces that Paul Forman has been appointed as a Non-Executive Director and a member of the Audit, Remuneration and Nominations Committees with effect from 1 January 2015.

Paul is Group Chief Executive of Coats plc, a leading industrial thread and consumer textile crafts business. Prior to joining Coats in 2009, he was Group Chief Executive of Low & Bonar PLC, a global performance materials group, and was previously Managing Director at Unipart International, a leading European automotive aftermarket supplier. Paul also served as a non-executive director at Brammer PLC from 2006 to 2010.

The Company further announces that Liz Airey, currently Chairman of the Audit Committee, will become Senior Independent Director and Anne Minto will assume the chairmanship of the Remuneration Committee with effect from 1 January 2015, after Robert Walker steps down from the Board following the completion of his term of appointment on 31 December 2014. Douglas Hurt will succeed Liz Airey as Chairman of the Audit Committee with effect from 1 March 2015 and will also replace her as a member of the Corporate Responsibility Committee from that date.

Sir Peter Gershon, Chairman of Tate & Lyle, said "I am delighted that Paul has agreed to join the Board. His wide experience of managing international businesses, developing business-to-business customer and market-led strategies, and commercialising innovation pipelines will be of significant benefit to the Board.

“I would also like to thank Robert for his nine years of exemplary service and significant contribution to the Board and the Remuneration Committee at a critical period in the Group’s transformation.”

There are no further disclosures to be made in connection with Mr Forman’s appointment pursuant to paragraph 9.6.13 of the Financial Conduct Authority’s Listing Rules.

For more information contact Tate & Lyle PLC:

Christopher Marsh, Group VP, Investor and Media Relations

Tel: +44 (0) 20 7257 2110 or Mobile: +44 (0) 7796 192 688

Andrew Lorenz (FTI Consulting), Media Relations

Tel: +44 (0) 20 7269 7113 or Mobile: +44 (0) 7775 641 807

About Tate & Lyle:

Tate & Lyle is a global provider of ingredients and solutions to the food, beverage and other industries, with operations in over 30 locations worldwide.

Tate & Lyle operates through two global divisions, Speciality Food Ingredients and Bulk Ingredients, supported by our Innovation and Commercial Development group. The Group's strategy is to become a leading global provider of Speciality Food Ingredients through a disciplined focus on growth, and by driving Bulk Ingredients for sustained cash generation to fuel this growth.

Speciality Food Ingredients consists of three platforms: Texturants, which includes speciality starches and stabilisers; Sweeteners, which comprises nutritive sweeteners and our range of no-calorie sweeteners including SPLENDA® Sucralose; and our Health and Wellness portfolio which includes speciality fibres and our salt-reduction offering. Additionally, our Food Systems business provides a wide variety of blended ingredient solutions.

Tate & Lyle Bulk Ingredients includes bulk sweeteners, industrial starches and fermentation products (primarily acidulants). Corn co-products from both divisions are primarily sold as animal feed.

Tate & Lyle is listed on the London Stock Exchange under the symbol TATE.L. American Depositary Receipts trade under TATYY. In the year to 31 March 2014, Tate & Lyle sales totalled £3.1 billion. http://www.tateandlyle.com.

SPLENDA® is a trademark of McNeil Nutritionals, LLC.

Copyright Business Wire 2014

Date   Source Headline
4th Jun 20145:33 pmBUSDirector/PDMR Shareholding
2nd Jun 20149:09 amBUSTotal Voting Rights
29th May 20145:15 pmBUSDirector/PDMR Shareholding
29th May 20147:01 amBUSEffect of Adoption of IFRS 11 ‘Joint Arrangements’
29th May 20147:00 amBUSFinal Results
1st May 201410:18 amBUSTotal Voting Rights
3rd Apr 20147:00 amBUSTrading Statement
2nd Apr 20144:45 pmBUSHolding(s) in Company
1st Apr 201410:25 amBUSTotal Voting Rights
5th Mar 20149:48 amBUSDirector/PDMR Shareholding
3rd Mar 201412:47 pmBUSDirector/PDMR Shareholding
20th Feb 20146:18 pmBUSHolding(s) in Company
17th Feb 201411:16 amBUSDirector/PDMR Shareholding
13th Feb 20142:58 pmBUSDirector/PDMR Shareholding
13th Feb 20147:01 amBUSInterim Management Statement
13th Feb 20147:00 amBUSNew Alliance with McNeil Nutritionals
13th Jan 201411:14 amBUSDirector/PDMR Shareholding
9th Jan 201412:54 pmBUSHolding(s) in Company
6th Jan 20143:34 pmBUSDirector/PDMR Shareholding
2nd Jan 201410:02 amBUSBlocklisting Interim Review
2nd Dec 201310:37 amBUSTotal Voting Rights
27th Nov 20135:13 pmBUSTransaction in Own Shares
26th Nov 20135:25 pmBUSTransaction in Own Shares
25th Nov 20136:04 pmBUSTransaction in Own Shares
22nd Nov 20135:23 pmBUSTransaction in Own Shares
21st Nov 20135:04 pmBUSTransaction in Own Shares
20th Nov 20135:22 pmBUSTransaction in Own Shares
19th Nov 20135:37 pmBUSTransaction in Own Shares
18th Nov 20135:37 pmBUSTransaction in Own Shares
8th Nov 20131:08 pmBUSDirector/PDMR Shareholding
7th Nov 20137:00 amBUSHalf-yearly Report
1st Nov 20139:06 amBUSTotal Voting Rights
4th Oct 20137:00 amBUSTrading Statement
30th Sep 201311:04 amBUSHolding(s) in Company
20th Sep 201312:02 pmBUSHolding(s) in Company
16th Aug 20139:21 amBUSHolding(s) in Company
5th Aug 20135:16 pmBUSDirector/PDMR Shareholding
1st Aug 201310:28 amBUSTotal Voting Rights
1st Aug 20139:18 amBUSDirector/PDMR Shareholding
24th Jul 20134:16 pmBUSResult of AGM
24th Jul 20137:00 amBUSInterim Management Statement
22nd Jul 20139:23 amBUSDirector/PDMR Shareholding
10th Jul 20139:03 amBUSDirector/PDMR Shareholding
8th Jul 20132:11 pmBUSHolding(s) in Company
5th Jul 20135:45 pmBUSDirector/PDMR Shareholding
4th Jul 20135:11 pmBUSTransaction in Own Shares
3rd Jul 20136:03 pmBUSTransaction in Own Shares
3rd Jul 20133:38 pmBUSDirector/PDMR Shareholding
2nd Jul 20135:17 pmBUSTransaction in Own Shares
1st Jul 20135:36 pmBUSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.